PATENT CLAIM ANALYSIS

Application Number: 16316714
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-09
Patent Classification: ["548", "364100"]

Abstract:
The invention relates generally to compounds that modulate the activity of TGFβR-1 and TGFβR-2, pharmaceutical compositions containing said compounds and methods of treating proliferative disorders and disorders of dysregulated apoptosis, such as cancer, utilizing the compounds of the invention.

Claim (Index 26):
A compound according to  claim 1  or a pharmaceutically acceptable salt thereof for use in the treatment of diseases or conditions for which a TGF\u03b2R antagonist is indicated.

Metadata:
- Claim Count in Document: 22.0
- Percentile: 99.0
- Lexical Diversity: 1.43333
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14977709', '14072563', '14819541', '14339123', '14820611']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7624846203543664
- 35 USC 102 Novelty (BERT): 0.5130116083493781
- Combined Prediction Score: 0.7375373191538676
- Mean Citation Score: 280.301294
- Max Citation Score: 286.54965
- Similarity Product: 193.6640611560434

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test